Dr. Hari Kiran is a distinguished Pharm D graduate from JNTU-Hyderabad, renowned for his expertise in Clinical Operations, Site Management, Project Management, and Clinical Research. Currently, he serves as a Senior Clinical Trial Global Specialist at Bristol Myers Squibb (BMS), a leading global pharmaceutical company recognized for its pioneering work in Oncology. In this role, Dr. Kiran oversees Phase 0, 1, and 2 studies in Southeast Asia, managing study allocation, vendor and CRO management, budgeting, and utilizing advanced systems like CTMS and e-TMF. His expertise lies in Cell Therapy, Gene Therapy, and Oncology therapeutics. Before joining BMS, Dr. Kiran was a Clinical Research Associate at Novo Nordisk, where he led the OSCD Department for Cardiology and Nephrology in Telangana. His exceptional performance earned him the title of Best Upcoming Rising Star - CRA for H1 2022 and a nomination for Best CRA for H1 2023. He has represented India in various international locations, collaborating with influential Key Opinion Leaders, including recipients of prestigious awards like Padma Shree and Padma Bhushan. Dr. Kiran began his career as a Clinical Research Coordinator at Klinera Global Services, contributing to Gilead Sciences projects in Gastroenterology. He is also an active educator, having trained over 200 students in Clinical Research, Operations, and Regulatory Affairs through Avenida. Additionally, he has served as a visiting faculty member at the Avanthi Institute of Pharmaceutical Sciences and has been invited as a distinguished speaker at various national and international sessions on topics such as clinical research, corporate culture, and professional skills.